Your browser doesn't support javascript.
loading
Impact of organism species on microbial eradication and development of resistance in severe gram-negative pneumonia.
Kiem, S; Schentag, J J.
Afiliación
  • Kiem S; School of Pharmacy, University of Buffalo, New York 14260, USA.
J Chemother ; 22(2): 103-9, 2010 Apr.
Article en En | MEDLINE | ID: mdl-20435569
This study evaluated the species differences in microbiological outcomes of Gram-negative bacteria (GNB) causing severe pneumonia from the viewpoint of area under the concentration-time curve/MIC ratio (AUC/MIC). In total, 111 strains of GNb from 74 patients were analyzed. Overall, microbiological eradication was achieved in 88% of the cases with initial AUC/MIC>119. However, relapse often occurred when resistance developed or AUC/miC was <176. Pseudomonas aeruginosa and Enterobacter spp. were commonly involved in failed microbiological eradication and development of resistance. The AUC/MIC required for initial eradication of P. aeruginosa was much higher (478) and antibiotic resistance in P. aeruginosa and Enterobacter spp. occurred less frequently with combination therapy (10.0% vs. 67.7%). These data argue that target magnitudes of AUC/MIC to eradicate GNB differ by species. Since antibiotic resistance developed in some species of GNB despite high AUC/MIC, strategies to minimize development of resistance, including combination therapy, must be considered.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Asunto principal: Infecciones por Bacterias Gramnegativas / Neumonía Bacteriana / Farmacorresistencia Bacteriana Múltiple / Antibacterianos Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Chemother Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Asunto principal: Infecciones por Bacterias Gramnegativas / Neumonía Bacteriana / Farmacorresistencia Bacteriana Múltiple / Antibacterianos Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Chemother Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos